Corcept Therapeutics (CORT)

• Market cap: $5.98B
• 1 day: -2.18%
• 5 days: -0.47%
• 1 month: -9.97%
• 3 months: 6.38%
• 6 months: 31.82%
• Year to date: 14.17%
• 1 year: 130.51%
• 5 years: 418.64%
• 10 years: 927.93%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

172% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 29

14% more funds holding

Funds holding: 317 [Q3] → 361 (+44) [Q4]

5% more capital invested

Capital invested by funds: $4.04B [Q3] → $4.24B (+$200M) [Q4]

3% less repeat investments, than reductions

Existing positions increased: 116 | Existing positions reduced: 120

3.26% less ownership

Funds ownership: 83.64% [Q3] → 80.38% (-3.26%) [Q4]

21% less call options, than puts

Call options by funds: $58.4M | Put options by funds: $73.7M

29% less funds holding in top 10

Funds holding in top 10: 7 [Q3] → 5 (-2) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $78 37% upside
• Avg. target: $108 89% upside
• High target: $130 128% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Piper Sandler David Amsellem 60% 1-year accuracy 21 / 35 met price target	37% upside $78	Overweight Maintained	27 Feb 2025
HC Wainwright & Co. Swayampakula Ramakanth 24% 1-year accuracy 48 / 198 met price target	102% upside $115	Buy Reiterated	27 Feb 2025
Canaccord Genuity Edward Nash 58% 1-year accuracy 11 / 19 met price target	128% upside $130	Buy Maintained	30 Jan 2025